Skip to content

Prospective Clinical Study of Unilateral or Bilateral Implantation of Intraocular Lens in Cataract Patients

Prospective Clinical Study of Unilateral or Bilateral Implantation of Intraocular Lens in Cataract Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04265820
Enrollment
120
Registered
2020-02-12
Start date
2019-10-28
Completion date
2020-08-01
Last updated
2020-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

unilateral cataract, binocular functional vision, Multifocal Intraocular Lenses

Brief summary

This is to evaluate the satisfaction of patient and postoperative functional vision of unilateral or bilateral Implantation of intraocular lens(IOLs) in cataract patients.

Detailed description

The subjects will undergo uneventful phacoemulsification and implantation of IOL. The subjects will be divided into two groups . The unilateral cataract patients in the Group 1 will undergo unilateral surgery, and the bilateral cataract patients in the Group 2 will undergo bilateral surgery. IOL may be monofocal,bifocal ,or trifocal,according to the patients preference and the eyes condition. In each group, the subjects will be divided into three subgroups according to the type of the IOLs.Compare binocular functional vision and the satisfaction of patient between the two groups at postoperative 3 months.Compare binocular functional vision and the satisfaction of patient with different IOLs among the subgroups.

Interventions

DEVICEunilateral implantation of IOL

unilateral phacoemulsification and implantation of IOL.IOL may be monofocal,bifocal ,or trifocal,according to the patients preference and the eyes condition.

DEVICEbilateral implantation of IOL

bilateral phacoemulsification and implantation of IOL.IOL may be monofocal,bifocal ,or trifocal,according to the patients preference and the eyes condition.

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with unilateral or bilateral age related cataracts * Regular corneal topography and Preoperative corneal astigmatism ≤ 0.75 Diopter

Exclusion criteria

* Pregnant or nursing women * In the presence of other ocular diseases that may affect the stability of the lens capsule (pseudoexfoliation syndrome, glaucoma, traumatic cataract, Marfan syndrome, etc.) * Pupil abnormality (non-reactive pupil, tonic pupils, abnormally shaped pupils, etc.) * History of any clinically significant retinal pathology or ocular diagnosis (e.g. diabetic retinopathy, ischemic diseases, macular degeneration, retinal detachment, optic neuropathy optic nerv atrophy, amblyopia, strabismus, microphthalmos, aniridia, epiretinal membrane etc.) in the study eyes that could alter or limit final postoperative visual prognosis. * Patients with history of ocular trauma or prior ocular surgery including refractive procedures * postoperative visual acuity of worse than 0.2 logMAR in any eye * Patients using systemic or ocular medication that affect visual acuity. * Patients participating in other clinical trials during the study.

Design outcomes

Primary

MeasureTime frameDescription
monocular and binocular visual acuity3 months postoperativelyuncorrected distance visual acuity (UCVA), intermediate visual acuity, near visual acuity will be measured at 5m, 80cm and 40cm respectively. All visual acuity measurements will be conducted under photopic conditions (85 cd/m2) and at 100% contrast

Secondary

MeasureTime frameDescription
Binocular Contrast sensitivity3 months postoperativelyContrast sensitivity measures will be conducted binocularly, under photopic, mesopic (5 cd/m2), photopic with glare and mesopic with glare conditions, with the OPTEC 6500 contrast sensitivity test (Stereo Optical, USA). Contrast sensitivity will be evaluated at five spatial frequencies (1.5, 3, 6, 12, and 18 cycles per degree \[cpd\]). Patients will be allowed 5 minutes to adapt to each illumination level before testing.
Binocular Defocus Curve3 months postoperativelyBinocular defocus curves will be obtained in all patients, positioned at 5m under photopic (\>85 cd/m 2 ) condition to measure the visual acuity with each defocus lens, representing the consecutive visual function of each eye. Negative lenses were added in 0.50 D steps and the visual acuity will be recorded for each type of defocus level. The procedure will be then repeated but with positive lenses. The range of defocus evaluated is from -4.00D to +2.00D.
stereopsis3 months postoperativelyUse block diagram of random-spot synoptophore to observe long distance stereopsis vision and yan's stereogram to observe short distance stereopsis vision.
Fusion function3 months postoperativelyThe fusion function of perception and movement (convergence and divergence)will be examined with a synoptophore.
Subjective visual quality3 months postoperativelyPhotic phenomena (score according to severity,0\ 4, higher scores mean worse)and spectacle dependence percentages will be evaluated by questionnaire.

Countries

China

Contacts

Primary ContactQianqian Lan
54283122@qq.com+8618607711972

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026